Not_yet_recruitingNCT07593066

The PRIORITY Study in Cervical Cancer: A Prospective Multicenter Observational Evaluation of an Integrated Molecular and Digital Model for Diagnostic Prioritization

Sponsor: Pontificia Universidad Catolica de Chile

Trial Details

ConditionCervical Cancer, Cervical Intraepithelial Neoplasia, HPV Infection
StatusNot_yet_recruiting
Participants700
Est. Completion31 Dec 2026
Last Updated18 May 2026

Primary Outcome

Diagnostic accuracy of the integrated molecular and digital model for detection of CIN2+

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: * Women aged 30 to 65 years * Eligible for cervical cancer screening according to national guidelines * Able and willing to provide informed consent * Able to perform self-sampling or attend clinical evaluation if required Exclusion Criteria: * Previous diagnosis of cervical cancer * History of total hysterectomy (removal of the cervix) * Current pregnancy if it precludes study procedures according to clinical judgment * Any medical or social condition that, in the opinion of the investigators, would interfere with participation or follow-up

Trial Sites

Countries

Chile
View Registry Entry

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service